{
    "2018-07-12": [
        [
            {
                "time": "",
                "original_text": "[推荐评级]医药国家药品监督管理局发布《接受药品境外临床试验数据的技术指导原则》点评：接受境外实验数据细则公布 新药上市“时差”有望显著缩短",
                "features": {
                    "keywords": [
                        "国家药品监督管理局",
                        "境外临床试验数据",
                        "技术指导原则",
                        "新药上市",
                        "时差缩短"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "万邦医药万格列净片获临床试验批准 用于Ⅱ型糖尿病",
                "features": {
                    "keywords": [
                        "万邦医药",
                        "万格列净片",
                        "临床试验批准",
                        "Ⅱ型糖尿病"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物涨0.94%，创近1个月新高，报50.52元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "股价上涨",
                        "新高"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "天士力：生物药平台价值初显 引领天士力价值重估",
                "features": {
                    "keywords": [
                        "天士力",
                        "生物药平台",
                        "价值重估"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}